M&A Report: The European Life Sciences Industry 2015

We are pleased to present to you the latest Carlsquare M[&]A Report:[nbsp]The European Life Sciences and Medtech Industry 2015. Together with our Globalscope partners we have analysed all published deals in three Life Sciences segments: Medtech, Pharma and Providers, with targets in Europe.

The study provides a detailed analysis of deal rationales as well as current trends and valuations. Some of the findings are:

• The total number of transactions in the European Life Science market grew by 13%
• There has been a 20% increase in the number of deals in the provider segment, which can be explained by the rising number of Private Equity funds conducting consolidations in this segment
• UK, Germany and France were the most attractive coutries for M[&]A, for the first time Italy entered the top 4[nbsp] ranking
• Most of the 883 deal were conducted intra-Europe
• With 96 transactions, again buyers from the United States were by far the most active investors from the outside of Europe

[nbsp]

If you are interested in receiving the report, please contact[nbsp]Carolina Liechtenstein.